[go: up one dir, main page]

ES2038264T3 - Un procedimiento para preparar compuestos heterociclicos de azufre aminoalquil-sustituidos. - Google Patents

Un procedimiento para preparar compuestos heterociclicos de azufre aminoalquil-sustituidos.

Info

Publication number
ES2038264T3
ES2038264T3 ES198888116179T ES88116179T ES2038264T3 ES 2038264 T3 ES2038264 T3 ES 2038264T3 ES 198888116179 T ES198888116179 T ES 198888116179T ES 88116179 T ES88116179 T ES 88116179T ES 2038264 T3 ES2038264 T3 ES 2038264T3
Authority
ES
Spain
Prior art keywords
alchyl
sulter
substituted
procedure
preparing amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888116179T
Other languages
English (en)
Inventor
Thomas J. Bargar
Lawrence C. Creemer
Robert J. Broersma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2038264T3 publication Critical patent/ES2038264T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPUESTOS NUEVOS HETEROCICLICOS DE AZUFRE SUSTITUIDOS POR AMINOALQUIL QUE SON UTILES COMO AGENTES ANTIHIPERTORES.
ES198888116179T 1987-10-02 1988-09-30 Un procedimiento para preparar compuestos heterociclicos de azufre aminoalquil-sustituidos. Expired - Lifetime ES2038264T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/104,195 US4894389A (en) 1987-10-02 1987-10-02 Novel aminoalkyl-substituted heterocyclic sulfur compounds

Publications (1)

Publication Number Publication Date
ES2038264T3 true ES2038264T3 (es) 1993-07-16

Family

ID=22299159

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888116179T Expired - Lifetime ES2038264T3 (es) 1987-10-02 1988-09-30 Un procedimiento para preparar compuestos heterociclicos de azufre aminoalquil-sustituidos.

Country Status (20)

Country Link
US (1) US4894389A (es)
EP (1) EP0310109B1 (es)
JP (1) JP2720177B2 (es)
KR (1) KR970001490B1 (es)
CN (1) CN1032792A (es)
AT (1) ATE71374T1 (es)
AU (1) AU606213B2 (es)
CA (1) CA1329618C (es)
DE (1) DE3867583D1 (es)
DK (1) DK547088A (es)
ES (1) ES2038264T3 (es)
FI (1) FI884454A7 (es)
GR (1) GR3003547T3 (es)
HU (1) HU202221B (es)
IL (1) IL87909A0 (es)
NO (1) NO884367L (es)
NZ (1) NZ226369A (es)
PH (1) PH25378A (es)
PT (1) PT88636B (es)
ZA (1) ZA887235B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
US4970228A (en) * 1989-10-23 1990-11-13 Merrell Dow Pharmaceuticals Novel aminoalkyl-substituted heterocyclic sulfur compounds
AU7044894A (en) * 1993-06-10 1995-01-03 University Of North Carolina At Chapel Hill, The (phospho)lipids for combatting hepatitis b virus infection
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
JP4259611B2 (ja) 1994-08-29 2009-04-30 ウェイク フォレスト ユニバーシティ ウィルス感染を治療するための脂質アナログ
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
US7551837B2 (en) 2001-08-31 2009-06-23 Thomson Licensing Sequence counter for an audio visual stream

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839321A (en) * 1966-07-21 1974-10-01 Smithkline Corp 5-sulfamoyl-n-(2-substituted-ethyl) anthranilic acids
US3859308A (en) * 1973-05-07 1975-01-07 Velsicol Chemical Corp Heterocyclic anilids

Also Published As

Publication number Publication date
ATE71374T1 (de) 1992-01-15
AU2293688A (en) 1989-04-06
DE3867583D1 (de) 1992-02-20
JPH01106880A (ja) 1989-04-24
PT88636A (pt) 1988-10-01
ZA887235B (en) 1989-05-30
KR970001490B1 (ko) 1997-02-06
JP2720177B2 (ja) 1998-02-25
NO884367L (no) 1989-04-03
EP0310109A2 (en) 1989-04-05
DK547088A (da) 1989-04-03
EP0310109B1 (en) 1992-01-08
CN1032792A (zh) 1989-05-10
PH25378A (en) 1991-06-03
HU202221B (en) 1991-02-28
NZ226369A (en) 1990-09-26
NO884367D0 (no) 1988-09-30
DK547088D0 (da) 1988-09-30
IL87909A0 (en) 1989-03-31
AU606213B2 (en) 1991-01-31
FI884454A0 (fi) 1988-09-28
EP0310109A3 (en) 1989-09-27
KR890006614A (ko) 1989-06-13
US4894389A (en) 1990-01-16
FI884454A7 (fi) 1989-04-03
GR3003547T3 (es) 1993-03-16
CA1329618C (en) 1994-05-17
HUT50465A (en) 1990-02-28
PT88636B (pt) 1992-12-31

Similar Documents

Publication Publication Date Title
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
ES2162198T3 (es) Agentes estrogenos.
MX9600484A (es) Anhidrato de clorhidrato de paroxetina y procedimiento para su preparacion.
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
PT80717B (pt) Processo para a preparacao de analogos de benzodiazepina
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
ES542322A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
ES2114876T3 (es) Hidroxialquilacion de fenoles o tiofenoles con carbonatos organicos ciclicos utilizando catalizadores de triorganofosfino.
PA8452701A1 (es) Agonistas de prostaglandinas
ES2184888T3 (es) Empleo de catalizadores de estaño, asi como mezclas reticulables que contienen estos catalizadores.
ES2038264T3 (es) Un procedimiento para preparar compuestos heterociclicos de azufre aminoalquil-sustituidos.
ES2054732T3 (es) Un procedimiento para preparar un derivado peptidico.
ES2058176T3 (es) Un procedimiento para preparar un derivado peptidico.
ES2001978A6 (es) Un procedimiento nuevo para la preparacion de analogos de 7-amino-mitosano
ES2032428T3 (es) Procedimiento para preparar (+)-biotina.
DE69000922D1 (de) Nichtmetallische dithiophosphate enthaltende schmiermittelgemische.
SV1995000012A (es) Acidos 5-vinil- y 5-etinil-quinolon- y-naftiridon-carboxilicos,ref. lea 30239-sv.
ES2082029T3 (es) Conjugados de acido difluoroglutamico con foliatos y antifoliatos para el tratamiento de enfermedades neoplasticas.
ES2052009T3 (es) Compuestos ciclicos que contienen azufre.
MX9606494A (es) Compuestos organicos.
ES2066927T3 (es) Procedimiento para la purificacion de polialquileneterglicoles, que contienen heteropoliacidos.
ES2039227T3 (es) Procedimiento para preparar derivados de imidazol.
ES2061687T3 (es) Di-t-butilfenoles sustituidos por un grupo alcoxi o benciloxi o por un grupo benciltio.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310109

Country of ref document: ES